mumbai reuters us food drug administration fda banned imports indian generic drugmaker sun pharmaceutical industries plant karkhadi gujarat latest quality blow indias drug sector
fda imposed rash regulatory sanctions indian generic makers last year triggering concerns quality medicines supplied 14 billion industry countries including united states biggest market
india second canada drug exporter united states supplies 40 percent generic overthecounter drugs
fda becoming stringent learning curve everyone invest said bk securities analyst rohit bhat companies pull quality parameters
immediately clear fda imposed ban sun pharmas karkhadi plant
fda issued import alert factory website said wednesday agency defines sanction something results detention without physical examination drugs firms met socalled good manufacturing practices
ban plant underscores growing concerns quality medicines made india often referred lowcost pharmacy world demand generics grows countries united states japan
sun pharma spokeswoman said financial impact fda ban us shipments plant makes antibiotic cephalosporin would negligible plant accounts less 1 percent overall sales said
sun pharma also said initiated several corrective steps address fdas concerns kept guidance consolidated sales fiscal year ending month
karkhadi plant one sun pharmas 25 manufacturing plants 11 india three plants including karkhadi plant gujarat
shares sun fell much 64 percent thursday
industry officials india say weak local regulatory oversight lax approach quality control drugmakers rush tap growing global demand generics result substandard manufacturing processes
urgency first generic version drug coming patent one reasons quality problems say company first launches drug enjoys sixmonth exclusivity period lucrative generic version commercial blockbuster
fda last month called collaboration indian regulator improve drug quality banned imports indian plants ranbaxy laboratories ltd indias no1 drugmaker sales production quality lapses
separately rival drug maker dr reddys laboratories ltd started recall 58656 bottles heartburn drug lansoprazole united states january due microbial contamination information posted fda website wednesday showed
spokesman dr reddys immediately available comment
also month fda announced drug recalls ranbaxy sun pharma
wockhardt ltd also barred exporting drugs plants united states britain
drugs ranbaxy wockhardt indian peers including dr reddys lupin ltd export united states cheaper copies drugs expired patent protection
company small managed strong supervision companies get bigger supervision break said chief executive officer top indian drugmaker
need systems culture maintain proper supervision process growing think said ceo declining identified
